Ted Buchan & Co’s Pfizer PFE Stock Holding History

Ted Buchan & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	54,689 +1,860	+4%	+$48.7K	0.43%	46
2026 Q1	$1.48M	Buy	52,829 +1,097	+2%	+$29.2K	0.54%	41
2025 Q4	$1.29M	Buy	51,732 +210	+0.4%	+$5.3K	0.47%	46
2025 Q3	$1.31M	Buy	51,522 +4,317	+9%	+$107K	0.51%	45
2025 Q2	$1.14M	Buy	47,205 +14,235	+43%	+$332K	0.45%	51
2025 Q1	$835K	Buy	32,970 +6,575	+25%	+$172K	0.4%	51
2024 Q4	$700K	Buy	+26,395	New	+$716K	0.33%	52
2023 Q4	–	Sell	-8,868	Closed	-$294K	–	83
2023 Q3	$294K	Sell	8,868 -2,270	-20%	-$80.3K	0.24%	60
2023 Q2	$409K	Sell	11,138 -5,509	-33%	-$214K	0.31%	53
2023 Q1	$679K	Buy	16,647 +2,049	+14%	+$88.5K	0.57%	39
2022 Q4	$748K	Buy	+14,598	New	+$700K	0.69%	34

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ted Buchan & Co's PFE Position: Q2 2026 in Review

Ted Buchan & Co increased its Pfizer (PFE) stake by 3.5% in Q2 2026, buying an estimated $48.7K and bringing the position to 54,689 shares worth $1.32M. The position accounts for 0.43% of the portfolio, ranked #46.

Ted Buchan & Co first reported a position in PFE in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.48M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Ted Buchan & Co held 54,689 shares of Pfizer worth $1.32M as of Q2 2026.
Ted Buchan & Co bought 1,860 Pfizer shares in Q2 2026, an estimated $48.7K.
Pfizer made up 0.43% of Ted Buchan & Co's portfolio in Q2 2026, its #46 holding.
Ted Buchan & Co first reported a position in Pfizer in Q4 2022 and has held it in 11 quarters since.
Ted Buchan & Co's Pfizer position peaked at $1.48M in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ted Buchan & Co's 13F filing for Q2 2026, filed 23 Jul 2026.